Arizona is joining a multistate consortium to help lower the cost of prescription drugs by up to 80%, Governor Katie Hobbs announced Wednesday.

In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the ...

A HMEDABAD, India, Aug. 6, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world's ...

The approval was based on pooled data from 50 patients in five open-label trials, showing an overall response rate of 22%, ...

A Rankin County teenager’s life-changing medication is being denied approval by the U.S. Food and Drug Administration, leaving him and many others with rare diseases unsure of their futures.

Smelling salts have long been used across numerous different sports as a stimulant for athletes, raising their awareness.

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

Baker Mayfield addressed the NFL’s 2025 smelling salts ban with sarcasm and hinted at a surprising new game day energy boost.

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...

Jazz Pharmaceuticals bet $1 billion on the commercial potential of a first-in-class oral imipridone for recurrent H3 K27M-mutant diffuse glioma.

Aurinia Pharmaceuticals Inc. achieved record Lupkynis sales of $66.6M in Q2 while managing cash flow. Click for insights on ...